Search
HomeEventsAnnual Partnering Forum

Meet us at the
12th Annual QNova Lifesciences Partnering Forum

JP Morgan Healthcare Week

12th – 15th January 2026 • San Francisco

QNova Life Sciences will host the annual Partnering Forum during the JP Morgan Healthcare Conference at the Hilton San Francisco Union Square hotel this January 2026 and online in February 2026. The event provides a unique opportunity for participating sponsors to meet emerging and established life science companies that require a broad range of professional services to advance their products to commercial success.

Come and meet us

Biointelect is a globally recognised Australian consulting and advisory firm offering a unique blend of full-service Contract Research Organisation (CRO) capabilities and consulting. With deep roots in the full health innovation ecosystem, Biointelect provides end-to-end support across the entire development pathway.

Leah Goodman, Biointelect's Chief Executive Officer
Leah Goodman
Chief Executive Officer
Jacqui Wade
Director, Clinical Affairs & Director Services

CRO services build for velocity and quality.

As a boutique CRO, Biointelect delivers a bespoke, science-driven model that adapts to the specific needs of each study. The experienced team’s agility and cross-functional collaboration ensure high-quality execution, streamlined communication, and fast, informed decision-making. Clients benefit from a single, dedicated point of contact overseeing all aspects of trial delivery, supported by a highly specialised team with deep early-phase expertise and a proven track record across complex clinical trials.

Regulatory without roadblocks.

From early strategy to dossier build and submissions, Biointelect guides ANZ, APAC and global regulatory pathways, coordinating queries, navigating designations to accelerate decision timelines. Our integrated consulting backbone connects R&D, CMC, market access and policy so your regulatory plan is technically sound and commercially rightsized.

Director Services for effortless Australian entry.

Biointelect’s Director Services are particularly valuable for international clients establishing Australian subsidiaries ensuring a smooth entry into the Australian research landscape, backed by Biointelect’s deep local knowledge and regulatory expertise. These services include governance setup, clinical trial oversight, and support for R&D tax claims, ensuring a smooth entry into the Australian research landscape.

Book a Meeting

We are available throughout this event to discuss how we can support your team across the entire development pathway.

Name
Preferred meeting date and time (if known)

The QNova LifeSciences™ Partnering Forum

The annual QNova LifeSciences™ Partnering Forum is an exclusive partnering and networking event that provides companies the opportunity to:

  • Meet strategic investors, key life science service providers, strategic partners and decision-makers.
  • Engage economic development organizations, industry associations, and trade partners to discover financial incentives and to make connections with high-level government officials.
  • Learn more about non-dilutive funding and partnership opportunities at the National Institutes of Health, US Department of Defence, US FDA, and the National Cancer Institute.

Eri Nishiuchi

Strategic Development and Business Effectiveness

Eri Nishiuchi holds a Bachelor of Business degree from the University of Technology Sydney. Her expertise lies in health systems analysis and client relationship management within the healthcare and life sciences sectors. She also has experience working with patient organisations.

Throughout her career, Eri has provided competitive landscape research support to pharmaceutical and biotech clients across the Asia Pacific region, achieving one of the top client retention rates in the region. Her multilingual abilities have been instrumental in fostering strong relationships with diverse stakeholders.

Eri joined Biointelect in 2024 in a strategic development and business effectiveness role, where her focus will be on conducting market analysis and improving business processes.